- Home
- PTIX vs TTNP Comparison
PTIX vs TTNP Comparison
Compare PTIX & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- TTNP
- Stock Information
- Founded
- PTIX 1994
- TTNP 1991
- Country
- PTIX United States
- TTNP United States
- Employees
- PTIX N/A
- TTNP N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PTIX Health Care
- TTNP Health Care
- Exchange
- PTIX Nasdaq
- TTNP Nasdaq
- Market Cap
- PTIX 3.9M
- TTNP 3.7M
- IPO Year
- PTIX 2016
- TTNP 1996
- Fundamental
- Price
- PTIX $0.64
- TTNP $3.81
- Analyst Decision
- PTIX
- TTNP
- Analyst Count
- PTIX 0
- TTNP 0
- Target Price
- PTIX N/A
- TTNP N/A
- AVG Volume (30 Days)
- PTIX 247.6K
- TTNP 8.5K
- Earning Date
- PTIX 11-29-2024
- TTNP 11-29-2024
- Dividend Yield
- PTIX N/A
- TTNP N/A
- EPS Growth
- PTIX N/A
- TTNP N/A
- EPS
- PTIX N/A
- TTNP N/A
- Revenue
- PTIX N/A
- TTNP $3,000.00
- Revenue This Year
- PTIX N/A
- TTNP N/A
- Revenue Next Year
- PTIX N/A
- TTNP N/A
- P/E Ratio
- PTIX N/A
- TTNP N/A
- Revenue Growth
- PTIX N/A
- TTNP N/A
- 52 Week Low
- PTIX $0.49
- TTNP $3.57
- 52 Week High
- PTIX $1.87
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- PTIX 49.61
- TTNP 34.23
- Support Level
- PTIX $0.52
- TTNP $3.77
- Resistance Level
- PTIX $1.09
- TTNP $4.66
- Average True Range (ATR)
- PTIX 0.15
- TTNP 0.28
- MACD
- PTIX 0.01
- TTNP 0.04
- Stochastic Oscillator
- PTIX 20.91
- TTNP 3.93
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's lead compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.